1. Home
  2. GRNQ vs VRAX Comparison

GRNQ vs VRAX Comparison

Compare GRNQ & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRNQ
  • VRAX
  • Stock Information
  • Founded
  • GRNQ 2013
  • VRAX 2013
  • Country
  • GRNQ Malaysia
  • VRAX United Kingdom
  • Employees
  • GRNQ N/A
  • VRAX N/A
  • Industry
  • GRNQ EDP Services
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GRNQ Technology
  • VRAX Health Care
  • Exchange
  • GRNQ Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • GRNQ 12.8M
  • VRAX 4.7M
  • IPO Year
  • GRNQ 2018
  • VRAX 2022
  • Fundamental
  • Price
  • GRNQ $2.12
  • VRAX $0.90
  • Analyst Decision
  • GRNQ
  • VRAX Strong Buy
  • Analyst Count
  • GRNQ 0
  • VRAX 1
  • Target Price
  • GRNQ N/A
  • VRAX $3.00
  • AVG Volume (30 Days)
  • GRNQ 84.5K
  • VRAX 66.0K
  • Earning Date
  • GRNQ 08-12-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • GRNQ N/A
  • VRAX N/A
  • EPS Growth
  • GRNQ N/A
  • VRAX N/A
  • EPS
  • GRNQ N/A
  • VRAX N/A
  • Revenue
  • GRNQ $3,190,761.00
  • VRAX $6,331.00
  • Revenue This Year
  • GRNQ N/A
  • VRAX $217,274.83
  • Revenue Next Year
  • GRNQ N/A
  • VRAX N/A
  • P/E Ratio
  • GRNQ N/A
  • VRAX N/A
  • Revenue Growth
  • GRNQ N/A
  • VRAX N/A
  • 52 Week Low
  • GRNQ $0.80
  • VRAX $0.74
  • 52 Week High
  • GRNQ $2.50
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • GRNQ 65.90
  • VRAX 56.08
  • Support Level
  • GRNQ $1.78
  • VRAX $0.84
  • Resistance Level
  • GRNQ $2.50
  • VRAX $0.98
  • Average True Range (ATR)
  • GRNQ 0.18
  • VRAX 0.08
  • MACD
  • GRNQ 0.04
  • VRAX 0.02
  • Stochastic Oscillator
  • GRNQ 63.11
  • VRAX 75.94

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: